Evidence map›Paper›PMID 31777200›Full record

ReviewInternational journal of rheumatic diseases2020

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.

James Cheng-Chung Wei, Chin-Hsiu Liu, Jui-Cheng Tseng, Lin-Fen Hsieh, Chun-Hsiung Chen, Hsin-Hua Chen, Hung-An Chen, Ying-Chou Chen, Chung-Tei Chou, Hsien-Tzung Liao and 6 more

Abstract readReviewConsensus Statement
In one paragraph

Review in International journal of rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

James Cheng-Chung WeiDivision of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-1235-0679
Chin-Hsiu LiuDivision of Allergy, Immunology and Rheumatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Jui-Cheng TsengDivision of Allergy, Immunology, and Rheumatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Lin-Fen HsiehDepartment of Physical Medicine and Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Chun-Hsiung ChenDivision of Allergy, Immunology and Rheumatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Hsin-Hua ChenDivision of Allergy-Immunology-Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Hung-An ChenDepartment of Allergy, Immunology, and Rheumatology, Chi Mei Medical Center, Tainan, Taiwan.
Ying-Chou ChenDepartment of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-9404-2900
Chung-Tei ChouDivision of Allergy, Immunology, Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsien-Tzung LiaoDivision of Allergy, Immunology, Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan.
Yi-Chun LinDepartment of Allergy, Immunology, and Rheumatology, Cheng Hsin General Hospital, Taipei, Taiwan.
Shue-Fen LuoDepartment of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan.
Deng-Ho YangDivision of Rheumatology/Immunology/Allergy, Department of Internal Medicine, Taichung Armed-Forces General Hospital, Taichung, Taiwan.ORCID https://orcid.org/0000-0001-8092-274X
Kai-Jieh YeoDivision of Rheumatology and Immunology, China Medical University Hospital, Taichung, Taiwan.
Wen-Chan TsaiDivision of Allergy, Immunology, and Rheumatology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-2777-4298
Taiwan Rheumatology Association (TRA)

Funding

Novartis TaiwanTaiwan Rheumatology Association
6 · The paper itself

Abstract

aimTo establish guidelines for the clinical management of axial spondyloarthritis that take into account local issues and clinical practice concerns for Taiwan.

methodOverarching principles and recommendations were established by consensus among a panel of rheumatology and rehabilitation experts, based on analysis of the most up-to-date clinical evidence and the clinical experience of panelists. All Overarching Principles and Recommendations were graded according to the standards developed by the Oxford Centre for Evidence Based Medicine, and further evaluated and modified using the Delphi method.

resultsThe guidelines specifically address issues such as local medical considerations, National Health Insurance reimbursement, and management of extra-articular manifestations.

conclusionIt is hoped that this will help to optimize clinical management outcomes for axial spondyloarthritis in Taiwan.

Indexed as

Antirheumatic AgentsDelphi TechniqueEvidence-Based MedicineHumansRheumatologySpondylarthritisTaiwanAntirheumatic Agentsankylosing spondylitisaxial spondyloarthritisextra-articular manifestationIL-17 inhibitornon-radiographic axial spondyloarthritisspinal fractureTNF inhibitor

Identifiers

PMID31777200
PMCPMC7004149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.